Repairing the 'broken middle' of the health innovation pathway: Exploring diverse practitioner perspectives on the emergence and role of 'translational medicine'

Science and Technology Studies

Volumn 26, Issue 3, 2013, Pages 103-123

  Mittra, James ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Innovation; R D; Translational Medicine

Indexed keywords

EID: 84893919803     PISSN: 22434690     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Academy of Medical Sciences (2011) A New Pathway for the Regulation and Governance of Health Research, January, 2011, available at http://www.acmedsci. ac.uk/p99puid209.html
2. Aronson, J.K., A.K. Cohen & L.D. Lewis. (2008) 'Clinical Pharmacology - Providing Tools and Expertise for Translational Medicine', British Journal of Clinical Pharmacology 65(2): 154-57.
3. Birch, K. (2012) 'Knowledge, Place and Power: Geographies of Value in the Bioeconomy', New Genetics and Society 31(2): 183-201.
4. Birch, K. & D. Tyfield (2012) 'Theorizing the Bioeconomy: Biovalue, Biocapital, Bioeconomies or* What?' Science, Technology and Human Values 38 (3): 299-327
5. BMJ (2008) 'Translational Research, Editorial', British Medical Journal 337: 863.
6. Borup, M., N. Brown., K. Konrad & H.V.Lente(2006) 'The Sociology of Expectations in Science and Technology', Technology Analysis and Strategic Management 18(3-4): 285-98.
7. Brown, N., B. Rappert & A. Webster (eds) (2000) Contested Futures: A Sociology of Prospective Techno-Science (Aldershot: Ashgate).
8. Calvert, J. (2010) Systems Biology, Interdisciplinarity and Disciplinary Identity, in Parker, J.N., N. Vermeulen & B. Penders (eds) Collaboration in the New Life Sciences (Aldershot: Ashgate): 201-218
9. Cohen, W.M. & D.A. Levinthal (1990) 'Absorptive Capacity: A New Perspective on Learning and Innovation', Administrative Science Quarterly 35: 128-52.
10. Cooksey. D (2006) A review of UK Health Research Funding, UK Department of Health available at http://www.official-documents.gov.uk/document/other/ 0118404881/0118404881.pdf.
11. Dougherty, D. & P.H.Conway (2008) 'The 3Ts Roadmap to Transform US Healthcare: The "How" of High-Quality Care', JAMA 299: 2319-21.
12. Drolet, B. & N. Lorenzi (2010) 'Translational Research: Understanding the Continuum from Bench to Bedside', Translational Research 157(1): 1-5.
13. FDA (2006) Critical Path Opportunities Report, US Department of Health and Human Services, March, 2006, available at http://www.fda.gov/downloads/ ScienceResearch/SpecialTopics/CriticalPathInitiative/ CriticalPathOpportunitiesReports/UCM077254.pdf.
14. FDA (2011) Advancing Regulatory Science at the FDA: A Strategic Plan, August, 2011, available at http://www.fda.gov/downloads/ScienceResearch/ SpecialTopics/RegulatoryScience/UCM268225.pdf.
15. Hara, T. (2003) Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development (London: Edward Elgar).
16. Henderson, R. (2000) 'Drug Industry Mergers Won't Necessarily Benefit R&D', Research Technology Management 43(4):10-1
17. Hoonaard, D.K. (2009) 'Moving Toward a Three-Way Intersection in Translational Research: A Sociological Perspective', Qualitative Health Research 19(12):1783-7.
18. Hopkins, M., P.A. Martin., P. Nightingale., A. Kraft & S. Mahdi (2007) 'The Myth of the Biotech Revolution: An Assessment of Technological, Clinical and Organisational Change', Research Policy 36 (4) 566-89
19. Morrison, M & L. Cornips (2012) 'Exploring the Role of Dedicated Online Biotechnology News Providers in the Innovation Economy', Science, Technology and Human Values 37(3): 262-85.
20. National Institutes of Health (2010) Scientific Management Review Board Report on Translational Medicine and Therapeutics, available at http:// smrb.od.nih.gov/dec/TMAT-Meeting- Formatted.pdf.
21. National Institutes of Health (2011) NIH Establishes National Center for Advancing Translational Sciences, NIH News, Friday, December 23, 2011, http://www.nih.gov/news/health/dec2011/od- 23.htm.
22. Nature (2008) 'Editorial, Crossing the Valley of Death', Nature 453: 840-42.
23. Niederhuber, J.E. (2010) 'Translating Discovery to Patient Care', JAMA 303: 1088-9.
24. Nelson, R.R. & B.N. Sampat (2001) 'Making Sense of Institutions as a factor Shaping Economic Performance', Journal of Economic Behavior and Organization 44: 31-54.
25. OECD (2009) 'The Bioeconomy to 2030: Designing a Policy Agenda', OECD Publishing, International Futures Programme, 21 April.
26. Pammolli, F., L. Magazzini & M. Riccaboni (2011) 'The Productivity Crisis in Pharmaceutical R&D', Nature Reviews Drug Discovery 19: 428-38.
27. Rafols, I., M.M. Hopkins., J. Hoekman., J. Siepel., A. O'Hare., A.P. Rodríguez & P. Nightingale (2012) 'Big Pharma, Little Science? A Bibliometric Perspective on Big Pharma's R&D Decline', Technological Forecasting and Social Change (in press)
28. Rubio, D.M., E.E. Schoenbaum & K. Esposito (2010) 'Defining Translational Research: Implications for Training', Academic Medicine 85(3): 470-5.
29. Saijo, N. (2002) 'Translational Study in Cancer Research', Internal Medicine 41: 770-3.
30. Schmid, E.F. & A. Smith (2005) 'Is Declining Innovation in the Pharmaceutical Industry a Myth?, Drug Discovery Today 10: 1031-38.
31. Soderquest, K. & G.M. Lord (2010) 'Strategies for Translational Research in the United Kingdom', Science Translational Medicine 2 (53): 1-5.
32. Stokes, D. (1997) Pasteur's Quadrant: Basic Science and Technological Innovation (Washington D.C: Brookings).
33. Sturdy, S. (2012) 'Looking For Trouble: Medical Science and Clinical Practice in the Historiography of Modern Medicine', Social History of Medicine 24(3): 739-57.
34. Tait, J & R. Williams (1999) 'Linear Plus Model: Policy Approaches to Research and Development', Science and Public Policy 26(2): 101-12.
35. Tait, J. (2007) 'Systemic interactions in life science innovation', Technology Analysis and Strategic Management 19(3): 257-77.
36. Tait, J., D. Wield., A. Bruce & J. Chataway (2008) 'Health biotechnology to 2030: Report to OECD International Futures Project'; 'The Bioeconomy to 2030: Designing a Policy Agenda', OECD Paris, available at http://www.oecd.org/dataoecd/12/10/40922867.pdf.
37. Terwilliger, J.D. & H.H. Goring (2009) 'Update to Terwilliger and Goring's "Gene Mapping in the 20th and 21st Centuries": Gene Mapping when Rare Variants are Common and Common Variants are Rare', Human Biology 81(5-6): 729-33.
38. Williams, R. (2006) 'Compressed Foresight and Narrative Bias: Pitfalls in Assessing High Technology Futures', Science as Culture 15(4): 327-48.
39. Weber, W.A. (2006) 'Positron Emission Tomography as an Imaging Biomarker', Journal of Clinical Oncology 24: 3282-92.
40. Wilson-Kovacs, D.M & C. Hauskeller (2012) 'The Clinician-Scientist: Professional Dynamics in Clinical Stem Cell Research', Sociology of Health and Illness 34(4): 497-512.
41. Woolf, S. (1974) 'Editorial: The Real Gap Between Bench and Bedside, New England Journal of Medicine 290: 802-3.